Dr Reddy's Laboratories Ltd

RDY 
(NYSE) 
 
$ 37.85 <%= Resources.Global.txtDown %>
Updated 14/07/2019
Change % -0.29% Stock price decreasing
Change -0.11 Stock price decreasing
Volume 30,357
High $ 38.27
Low $ 37.79
Open $ 38.14
ISIN
Prev close $ 37.96
# of shares 22.61M
Market cap 855.71M USD
Intraday

Market closed
Dr Reddy\'s Laboratories Ltd
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  37.85 0.1% Stock price increasing 2.1% Stock price increasing -5.4% Stock price decreasing 2.1% Stock price increasing 27.1% Stock price increasing
Powered by TradingView

Company profile

Dr Reddy's Laboratories Ltd develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, proprietary products, and active chemical ingredients. The global generics and pharmaceutical services and active ingredients segments make up most of the company's revenue at about 76% and 19%, respectively. About 82% of Dr. Reddy's sales are based outside of India, with approximately 48% from the United States.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 July 2019 01:56:02
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB3 - 2019-07-16 02:56:02 - 2019-07-16 01:56:02 - 1000 - Website: OKAY